Infotree Global Solutions · 3 hours ago
Research Operations Senior Associate-Solid phase synthesis
Infotree Global Solutions is seeking a Research Operations Senior Associate to support discovery research. The successful candidate will execute peptide synthesis and antibody conjugation workflows, ensuring high-quality materials are delivered to project teams while maintaining day-to-day lab readiness.
Responsibilities
Under minimal supervision, plan and set up peptide synthesis, and perform peptide cleavage and purification using RP-HPLC
Conduct antibody conjugation experiments
Analyze and confirm peptide and conjugate identity and purity
Accurately record all experimental procedures, observations and results in the laboratory enotebook
Communicates data and interpretation to work group
Operate and maintain specialized lab equipment and instrumentation
Perform general lab housekeeping activities, ensuring a clean, safe workspace
Comply with all lab safety guidelines, SOPs and relevant regulations
Qualification
Required
Master's degree in chemistry, biochemistry, or a related scientific discipline; or Bachelor's degree in chemistry, biochemistry, or a related scientific discipline with 2+ years of relevant experience
Solid understanding of standard laboratory practices
Hands-on experience with solid phase peptide synthesis and RP-HPLC purification
Experience operating and maintaining laboratory instrumentation
Preferred
Solid phase synthesis experience
Solid phase peptide synthesis experience
Company
Infotree Global Solutions
Infotree Global Solutions is a talent management company specializing in staffing and payroll solutions.
H1B Sponsorship
Infotree Global Solutions has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (8)
2024 (9)
2023 (11)
2022 (17)
2021 (16)
2020 (19)
Funding
Current Stage
Late StageTotal Funding
unknownKey Investors
Kingswood Capital Management
2025-02-20Private Equity
Recent News
Company data provided by crunchbase